Jean-Pierre Dangy Selected Research

Jean-Pierre Dangy Research Topics

5	Buruli Ulcer 01/2021 - 01/2013
4	Malaria 04/2024 - 01/2020
3	Infections 01/2021 - 01/2020
3	Skin Diseases (Skin Disease) 01/2020 - 01/2013
2	Parasitemia 01/2021 - 01/2020
2	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2013 - 07/2005
1	Viremia 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Meningitis 10/2014

4	VaccinesIBA 04/2024 - 10/2014
3	mycolactoneIBA 01/2021 - 01/2017
3	MacrolidesIBA 01/2020 - 01/2013
3	ExotoxinsIBA 01/2019 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2022
2	Polysaccharides (Glycans)IBA 04/2024 - 10/2014
2	AntigensIBA 01/2022 - 10/2014
2	Cytotoxins (Cytolysins)IBA 01/2021 - 01/2020
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2021 - 01/2020
2	Capsules (Microcapsules)IBA 10/2014 - 07/2005
1	LectinsIBA 04/2024
1	Nucleic AcidsIBA 01/2022
1	Histidine (L-Histidine)FDA Link 01/2022
1	5' Untranslated Regions (5' UTR)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	ChemokinesIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CytokinesIBA 01/2021
1	Reagent StripsIBA 09/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	AntibodiesIBA 10/2014
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2013
1	PolyketidesIBA 01/2013
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2005

1	Immunotherapy 04/2024